INCY - Calithera nixes 2017 collaboration deal with Incyte September, 04 2020 08:40 AM Incyte Corporation Calithera Biosciences (NASDAQ:CALA) discloses that it has delivered written notice to Incyte (NASDAQ:INCY) terminating their January 2017 collaboration and license agreement effective September 30.More news on: Calithera Biosciences, Inc., Incyte Corporation, Healthcare stocks news, Read more ...